Open Access Article
This Open Access Article is licensed under a
Creative Commons Attribution 3.0 Unported Licence

Correction: Structure-based design, synthesis, and biological activity evaluation of chalcone–piperazine derivatives as dual AChE and MAO B inhibitors

Berkant Kurbanabc, Begüm Nurpelin Sağlık Özkanbd, Derya Osmaniyebd, Serkan Leventde, Yusuf Özkaybd and Zafer Asım Kaplancıklı*bf
aDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Afyonkarahisar Health Sciences University, 03030 Afyonkarahisar, Turkey
bDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University, 26470 Eskişehir, Turkey. E-mail: zakaplan@anadolu.edu.tr
cThe Institute of Graduate Education, Anadolu University, 26470 Eskişehir, Turkey
dCentral Research Laboratory (MERLAB), Faculty of Pharmacy, Anadolu University, 26470 Eskişehir, Turkey
eDepartment of Analytical Chemistry, Faculty of Pharmacy, Anadolu University, 26470 Eskişehir, Turkey
fPharmacy Services, Vocational School of Health Services, Bilecik Şeyh Edebali University, 11000, Bilecik, Turkey

Received 10th November 2025 , Accepted 10th November 2025

First published on 19th November 2025


Abstract

Correction for ‘Structure-based design, synthesis, and biological activity evaluation of chalcone–piperazine derivatives as dual AChE and MAO B inhibitors’ by Berkant Kurban et al., RSC Adv., 2025, 15, 40897–40911, https://doi.org/10.1039/D5RA05397H.


The authors regret that details of the funding information were omitted from the Acknowledgements of the original manuscript. The correct Acknowledgements are as shown below.

Acknowledgements

As the authors of this study, we thank Anadolu University Faculty of Pharmacy Central Research Laboratory (MERLAB), for their support and contributions. This study was supported by Anadolu University under the Scientific Research Projects (BAP) program, Project Code: YTT-2025-2710. Additionally, this study is a master’s thesis. YÖK Thesis number: 806986.

The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.


This journal is © The Royal Society of Chemistry 2025
Click here to see how this site uses Cookies. View our privacy policy here.